This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

Individualising Care Matters: The increasing complexities of managing metastatic breast cancer

Prescribing information can be found at the bottom of the page.


Join us on 23 May 2024 to hear from Professor Srinivasan Madhusudan,Professor of Medical Oncology, Professor Nadia Harbeck, Consultant Oncologist, Dr Nicolò Matteo Luca Battisti, Consultant Medical Oncologist and Dr Marina Parton,Consultant Medical Oncologist discussing 'Individualising Care Matters: The increasing complexities of managing metastatic breast cancer' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCP's and may include reference to medicines or vaccines promoted by Pfizer. 

Prescribing information can be found at the bottom of the page.


Join us on 23 May 2024 to hear from Professor Srinivasan Madhusudan,Professor of Medical Oncology, Professor Nadia Harbeck, Consultant Oncologist, Dr Nicolò Matteo Luca Battisti, Consultant Medical Oncologist and Dr Marina Parton,Consultant Medical Oncologist discussing 'Individualising Care Matters: The increasing complexities of managing metastatic breast cancer' followed by a live interactive Q&A.

This promotional meeting is organised and funded by Pfizer Ltd for UK HCP's and may include reference to medicines or vaccines promoted by Pfizer. 

Event Date23 May 2024 18:25 BSTDuration1 Hr 35 AudienceConsultants, Nurses, Pharmacists, Specialist Registrars {{givenName}}%20{{familyName}}%20has%20shared%20a%20resource%20with%20you%3B%20please%20click%20the%20link%20below%3A%0D%0A%0D%0A{{URL}}%0D%0A%0D%0AThank%20you%2C%0D%0A{{givenName}}%20{{familyName}}
Agenda
Meeting Agenda 18:00 - 18:25Joining & Registration
18:25 - 18:30Introduction to PfizerPro video Allister Burrell, Pfizer Ltd.
18:30 - 18:35Welcome and Introduction Srinivasan Madhusudan - Professor
18:35 - 18:45CDK inhibitors in the real world: The Nottingham experience Srinivasan Madhusudan - Professor
18:45 - 19:10The evolving mBC landscape: An international oncologist’s perspective Nadia Harbeck - Professor
19:10 - 19:30Geriatric Oncology: Moving the needle towards evidence-based precision oncology for older adults with breast cancer Nicolò Matteo Luca Battisti - Dr
19:30 - 19:45Case Histories: Exploring Boundaries in mBC Marina Parton - Dr
19:45 - 20:00Questions & Answers Srinivasan Madhusudan - Professor Nadia Harbeck - Professor Nicolò Matteo Luca Battisti - Dr Marina Parton - Dr
20:00Meeting close
Speakers
Event Speakers
Srinivasan Madhusudan, Professor
Srinivasan Madhusudan, ProfessorConsultant Oncologist , Nottingham University Hospitals NHS Trust

Medical Oncology training at Oxford.

PhD at the Weatherall Institute of Molecular Medicine at Oxford.

2007- Clinical Associate Professor in Medical Oncology at the University of Nottingham.

2016- Professor of Medical Oncology in Medical Oncology at the University of Nottingham.

Currently also: 

Cancer Lead for East Genomic Medicine Service Alliance, Director of Naaz-Coker Ovarian Cancer Research Centre at the Biodiscovery Institute at the University of Nottingham.

Head of Translational DNA Repair Research Group at the Biodiscovery Institute at the University of Nottingham.

Authored over 160 peer reviewed research publications and edited 2 books.

Nadia Harbeck, Professor
Nadia Harbeck, ProfessorConsultant Oncologist: Director of Breast Centre, University of Munich (LMU)

Professor Harbeck heads the Oncological Therapy & Clinical Trials Unit, Dept. OB&GYN and the Center for Hereditary Breast and Ovarian Cancer.

She is the director of the Breast Center and holds the chair for Conservative Oncology at the Dept. of OB&GYN, LMU University Hospital, Munich, Germany. 

Professor Harbeck is a Steering Committee Member of the Comprehensive Cancer Center Munich.

She is a recipient of the 2020 ESMO Lifetime Achievement Award.

Professor Harbeck is principal investigator or steering committee member of numerous breast cancer trials, particularly with novel targeted compounds and individualized treatment strategies. Her translational research focusses on prognostic and predictive factors in breast cancer and other malignancies. She has a strong interest in eHealth and is a co-developer of CANKADO, an international digital patient diary.

Professor Harbeck is one of the most frequently cited clinical researchers worldwide. She has authored more than 570 papers in peer-reviewed journals and many book chapters.

 

Nicolò Matteo Luca Battisti, Dr
Nicolò Matteo Luca Battisti, DrConsultant Medical Oncologist, The Royal Marsden NHS Foundation Trust

No Biography Available.

Marina Parton, Dr
Marina Parton, DrConsultant Medical Oncologist, The Royal Marsden NHS Foundation Trust

No Biography Available

Ibrance®(palbociclib) 

Prescribing Information

Talzenna®(talazoparib tosylate) 

Prescribing Information

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

PP-IBR-GBR-5748. May 2024

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​